Could Non-malignant Diseases be Drivers of Thrombocytosis?

Dawn O'Shea

November 19, 2020

Over half of patients with thrombocytosis have a pre-existing condition that could explain a high blood count, according to research published in the British Journal of General Practice.

The prospective cohort study used data from the English Clinical Practice Research Datalink 2000-2013 to estimate the one-year incidence of non-malignant diseases in patients with new thrombocytosis and the incidence of pre-existing non-malignant diseases in patients who develop new thrombocytosis. Fifteen candidate non-malignant diseases were identified from literature searches.

In the thrombocytosis cohort of 39,850 patients, 4579 (11.5%) were newly diagnosed with any one of the candidate diseases, compared with 443 out of 9684 patients (4.6%) with normal platelet count cohort (risk ratio, 2.5; 95% CI, 2.3-2.8). Iron-deficiency anaemia was the most common new diagnosis.

A total of 22,612 (56.7%) patients with thrombocytosis had a pre-existing non-malignant diagnosis compared with 4846 patients (50%) in the normal platelet count cohort (OR, 1.3; 95% CI, 1.2-1.4).

There was no statistically significant difference in cancer diagnoses between patients with and without pre-existing disease in the thrombocytosis cohort.

Although cancer is one of the primary clinical considerations when faced with a case of unexplained thrombocytosis, the study authors suggest that non-malignant conditions, like inflammatory bowel disease, giant cell arteritis and rheumatoid arthritis, may be the explanation.

“It seems reasonable to defer cancer investigation in a patient with one of those existing conditions, unless the patient has symptoms of a possible cancer."

Clarke C, Hamilton W, Price S, Bailey SER. Association of non-malignant diseases with thrombocytosis: a prospective cohort study in general practice. Br J Gen Pract. 2020 Nov 16 [Epub ahead of print]. doi: 10.3399/bjgp20X713501 View full text

This article originally appeared on Univadis, part of the Medscape Professional Network.

 
 

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....